Regeneron Plans $2 Billion Expansion in Saratoga Springs
Written by AI under direction and editing of Saratoga Report Publisher Dan De Federicis
SARATOGA SPRINGS — Biotechnology giant Regeneron Pharmaceuticals is planning a $2 billion investment in a major new facility in Saratoga Springs, marking one of the largest private developments in the city’s history. The project is expected to create up to 1,000 high-paying jobs and further solidify New York’s Capital Region as a hub for life sciences innovation.
According to early plans, Regeneron intends to use the former Quad Plant in the WJ Grande Industrial Park off Geyser Rd. The new complex would complement the company’s existing operations in East Greenbush and Rensselaer, expanding research, manufacturing, and distribution capacity for its growing portfolio of biopharmaceutical products.
Regeneron, one of New York State’s largest employers, has experienced rapid growth in recent years as demand for its treatments continues to expand worldwide. If approved, the Saratoga Springs site would represent a major milestone in the company’s long-term growth strategy and a significant boost to the region’s life sciences corridor.
This news was first published by the Albany Business Review. That publication’s article can be linked here. It is subject to paywall, but the Business Review often offers reduced introductory pricing.
